Virogin Biotech
Robert L. Martuza, M.D. is a Distinguished Professor of Neuroscience at Harvard Medical School and Chief Emeritus of Neurosurgery Service at Massachusetts General Hospital. His pioneering work has led multiple other investigators to study other oncolytic viruses for cancer therapy and to the approval of two different oncolytic viruses for clinical use worldwide. Dr. Martuza has published over 200 peer-reviewed articles on oncolytic virotherapy, cancer therapy and immunotherapy, and brain neoplasms.
This person is not in the org chart
This person is not in any offices
Virogin Biotech
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need.